We haven't moved on much in terms of tackling #stigma associated with #STIs & the barriers this creates to improving STI control. This poster from 1937 highlighted by Nicola Low #EveryDayCounts #StillFBPE wouldn't look out of place today #IUSTI2024

🚨Kicking off today. #IUSTI2024 Sydney with World Health Organization (WHO) Mobilizing for #STI (sexually transmitted infections) in pillars of 📢 Innovation 📢 Political commitment 📢 Community engagement Follow for updates International Union against STIs Michael Marks Prof Andrew Grulich Ismaël Maatouk

This morning, World Health Organization (WHO) had a joint IAS-IUSTI-WHO session in #HIVAIDS2024 #IUSTI2024 ASHM on “Mobilize for action on #STIs” Three critical accelerators were discussed with framing session and panelists from different geographic and expertise backgrounds: - innovation -

Opening ceremony ASHM #IUSTI20204 #STIs

Congress President Great efforts to make this congress happen Eric Chow ASHM #IUSTI2024

#Syphilis: one disease, several epidemics Michael Marks touching on a hot topic #IUSTI2024

Inspiring discussion on #doxyPEP and #STIs prevention at the opening ceremony #IUSTI2024 Troy Grennan MD MSc FRCPC

MenGo in Australia: Gay and bisexual men who received 2 doses of 4CMenB had a reduced incidence of gonorrhoea although this did not reach statistical significance ☹️ Crucial findings by Kate Seib #STIs #IUSTI2024 ASHM

Well done Jane Hocking !!

Keynote from Jane Hocking #IUSTI2024 what we have learnt about Chlamydia. Highlights incredible Accept RCT - Does community screening for Chlamydia reduces transmission The Lancet thelancet.com/journals/lance… Short answer at likely achievable levels of screening answer is NO

Don’t miss World Health Organization (WHO)’s second session at ASHM #IUSTI2024 this morning: Strategies to outsmart AMR in gonorrhoea Surveillance, diagnostics, new treatment, and other related issue including gonorrhoea models in the era of DoxyPEP will be discussed! #STIs

At #IUSTI2024 Dimie Ogoina gave a great talk about the alarming rise of #mpox in #DRC Highlights the essential research of Pathogen Genomic Lab - INRB in defining new clade Ib, showing first cases of sexually-associated clade Ia and Ib, national and international spread, leading to #mpox #PHEIC2

Dr John Saunders speaking about antibiotic stewardship in the context of DoxyPEP and STI testing #IUSTI2024 ASHM

Very thoughtful session by John Saunders on antimicrobial stewadrship #IUSTI2024 ASHM

Great news of today! Eagle 1: oral gepotidacin non inferior to ceftriaxone 500 mg plus azithrmycin 1 g in treating urogenital gonorrhoea per culture-based assessment #IUSTI2024 ASHM

Last day at #IUSTI2024 with an exciting World Health Organization (WHO) session 🗣️(re)-Emerging #STIs 🦠 Topics include #mpox #syphilis and scabies

Thanks to all colleagues who joined a fully packed WHO session yesterday on Antimicrobial Resistance in Neisseria gonorrhoeae. Topics included Global epidemiology, with country focus from Australia and China, new diagnostics, potential new treatments and new doxyPEP models.

Another very instructive gonorrhoea session with Jason Ong and Kate Seib and Magnus Unemo #IUSTI2024

Wrapping up at #IUSTI2024 International Union against STIs - huge thanks to Eric Chow for organising a fabulous meeting. See you all at #ISSTDR2025 in Montreal

Two key groups were notably absent from this year's IUSTI World Congress, likely due to the challenges of long travel and overlapping commitments: 1) The French team from Saint Louis Hospital, Paris, who trained me in #STIs. Their venerable Venereal Diseases clinic has been at